Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fokus Mining Intersects 10 Metres Grading 10.06 G/T At The Galloway Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News bluebird bio Inc BLUE

Healthcare Biotechnology
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BLUE)

BLUE LAWSUIT ALERT: Levi & Korsinsky Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire 50 minutes ago

Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire 2 hours ago

Contact Levi & Korsinsky by May 28, 2024 Deadline to Join Class Action Against bluebird bio, Inc.(BLUE)

Accesswire 2 hours ago

BLUE INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE

Newsfile 3 hours ago

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE

Accesswire 5 hours ago

ROSEN, NATIONAL TRIAL LAWYERS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE

PR Newswire 6 hours ago

bluebird bio, Inc. Class Action: Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE

Accesswire 7 hours ago

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm

Newsfile 9 hours ago

May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE

PR Newswire 16 hours ago
View More News ››

Opinion & Analysis (NDAQ:BLUE)

Coverage Initiated on Cancer Vaccine Firm

Streetwise Reports March 11, 2019

Risk Versus Reward: The Value of Cell Therapy for Patients and Investors

Streetwise Reports April 25, 2018

Partnerships propel Stellar Biotechnologies' vaccine technology

The Life Sciences Report June 22, 2016

CAR T-cell therapeutics: Alan Leong of BioWatch looks beyond the buzz for solid early-stage plays

Gail Dutton September 10, 2015

Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

George S. Mack September 3, 2015

Zacks' Jason Napodano is not focused on a biotech bubble

George S. Mack July 9, 2015
View More Opinion ››

Bullboard Posts (NDAQ:BLUE)

"durable disease remissions for up to 5 years"

https://www.medscape.com/viewarticle/sickle-cell-gene-therapy-truly-transformative-2023a1000uso
Quint13 - December 14, 2023

Approved Dec 8

https://www.businesswire.com/news/home/20231209650405/en/Long-term-Follow-up-Data-From-bluebird%E2%80%99s-Gene-Therapy-Program-in-Sickle...
Quint13 - December 9, 2023

RE:TD WATERHOUSE TOP 10 IN BIOTECHNOLOGY STOCKS

They should add EDT and SQD to their list .... like around the top. IMHO
inspecthrgadget - July 9, 2020

TD WATERHOUSE TOP 10 IN BIOTECHNOLOGY STOCKS

TD WATERHOUSE TOP 10 IN BIOTECHNOLOGY STOCKS Top 10 : 1.TRIL 2. BU 3. IBT 4. MDNA 5. APS 6. GENX 7. BLU 8. MBX 9. ARCH 10. MIR
TheBearInTheWoods - May 9, 2020

RE:RE:Amazing cure for bladder / brain cancer with laser tech

GRAMPS1996 - August 27, 2018

RE:Amazing cure for bladder / brain cancer with laser tech

An interesting Canadian company brother love. Difficult finding info. Found some news on yahoo.  Will keep an eye on it. 
norjase - August 27, 2018
View more Bullboard ››

Fobi AI Inc

Fobi AI Inc

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the ...
View More »